CROWN IN THE RIGHT OF THE QUEE has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are AVIR GREEN HILLS BIOTECHNOLOGY RES DEV TRADE AG, SHANGHAI CLEAR FLUID BIOMEDICAL SCIENCE CO LTD and GREEN CROSS LAB CELL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | New Zealand | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Gowans Eric James | 7 |
#2 | Macnaughton Thomas Bernard | 6 |
#3 | Varnavski Andrei | 5 |
#4 | Westaway Edwin G | 5 |
#5 | Khromykh Alexander A | 5 |
#6 | Netter Hans Jurgen | 3 |
#7 | Harvey Tracey Jane | 2 |
Publication | Filing date | Title |
---|---|---|
CA2417719A1 | Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) | |
AU7618201A | Improved virus like particles based on small envelope protein from hepatitis B (HBsAg-S) | |
US6893866B1 | Flavivirus expression and delivery system | |
AUPQ371699A0 | Retroviral vector system and components therof | |
AUPQ265299A0 | An HCV therapeutic | |
AUPQ225699A0 | An hcv therapeutic | |
AUPP850199A0 | Hbv binding protein | |
AU1551799A | Flavivirus expression and delivery system | |
AU9730298A | Hbv binding polypeptide | |
AUPP609698A0 | Flavivirus expression system | |
AU7871698A | Hepatitis delta particle containing a fusion protein immunogen | |
AUPP062797A0 | Flavivirus expression system | |
AUPP004197A0 | Novel hbv binding protein and portions thereof | |
AUPO434196A0 | An improved therapeutic |